PRESS RELEASE published on 02/13/2024 at 00:00, 2 years ago KBC Group: Fourth-quarter result of 1 116 million euros
PRESS RELEASE published on 02/13/2024 at 00:00, 2 years ago KBC Groupe: Résultat du quatrième trimestre: 1 116 millions d'euros
PRESS RELEASE published on 02/13/2024 at 00:00, 2 years ago KBC Groep: Resultaat vierde kwartaal van 1 116 miljoen euro
Published on 02/22/2026 at 23:45, 4 hours 20 minutes ago Barton Distributes $640,000 in JMEI Tax Credits
Published on 02/21/2026 at 00:45, 2 days 3 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 2 days 3 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 2 days 5 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/23/2026 at 03:26, 38 minutes ago AGTech to Help Build One-Stop Trading Services Platform as Hong Kong Gold Exchange Opens for the Year of the Horse
Published on 02/22/2026 at 12:19, 15 hours 45 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 17 hours 55 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 16 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 16 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 19:29, 2 days 8 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
